MedPath

江苏大红鹰恒顺药业有限公司

Ownership
-
Established
2001-08-06
Employees
-
Market Cap
-
Website
www.dhyhs.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

105

NMPA:105

Drug Approvals

Tobramycin Sulfate Injection

Product Name
硫酸妥布霉素注射液
Approval Number
国药准字H20033243
Approval Date
Sep 7, 2023
NMPA

Calcium Folinate Injection

Product Name
法益宁
Approval Number
国药准字H20010804
Approval Date
Jun 13, 2023
NMPA

Clindamycin Phosphate Injection

Product Name
特丽仙
Approval Number
国药准字H20013397
Approval Date
May 5, 2023
NMPA

Clindamycin Phosphate Injection

Product Name
特丽仙
Approval Number
国药准字H10983228
Approval Date
Feb 8, 2023
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20163133
Approval Date
May 26, 2021
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20153087
Approval Date
May 26, 2021
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20153086
Approval Date
May 26, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32026184
Approval Date
Nov 26, 2020
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H32022540
Approval Date
Oct 10, 2020
NMPA

Carbocisteine Tablets

Product Name
羧甲司坦片
Approval Number
国药准字H32020490
Approval Date
Oct 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.